The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The predictive role of integrated BRCA1 and HERC2 mRNA expression in advanced non-small cell lung cancer (NSCLC) patients (p) treated with platinum-based first-line chemotherapy.
Laura Bonanno
No relevant relationships to disclose
Carlota Costa
No relevant relationships to disclose
Jose Javier Sanchez
No relevant relationships to disclose
Margarita Majem
No relevant relationships to disclose
Ana Gimenez Capitan
No relevant relationships to disclose
Ignacio Rodriguez
No relevant relationships to disclose
Alain Vergnenegre
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Adolfo G. Favaretto
No relevant relationships to disclose
Massimo Rugge
No relevant relationships to disclose
Cinta Pallares
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose